Real World Efficacy of Pembrolizumab of as a 1st Line Treatment in Metastatic Non-Small Cell Lung Cancer with PD-L1 High Expression

被引：0
|
作者：
Kasahara, K. [1 ]
Sone, T. [1 ]
Nishi, K. [2 ]
Shibata, K. [3 ]
Araya, T. [4 ]
Shirasaki, H. [5 ]
Yoneda, T. [6 ]
Kase, K. [7 ]
Nishikawa, S. [1 ]
Kimura, H. [1 ]
Tambo, Y. [1 ]
机构：
[1] Kanazawa Univ, Resp Med, Kanazawa, Ishikawa, Japan
[2] Ishikawa Prefectural Cent Hosp, Resp Med, Kanazawa, Ishikawa, Japan
[3] Kouseiren Takaoka Hosp, Med Oncol, Takaoka, Toyama, Japan
[4] Natl Hosp Org Kanazawa Med Ctr, Resp Med, Kanazawa, Ishikawa, Japan
[5] Fukui Ken Saiseikai Hosp, Resp Med, Fukui, Japan
[6] Komatsu Municipal Hosp, Resp Med, Komatsu, Japan
[7] Keiju Med Ctr, Resp Med, Nanao, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
Pembrolizumab; 1st line treatment; PD-L1 high expression;
D O I：
10.1016/j.jtho.2019.08.953
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.04-50
引用
收藏
页码：S460 / S460
页数：1
相关论文
共 50 条
  • [31] PD-L1 expression: An emerging biomarker in non-small cell lung cancer
    Adam, Julien
    Planchard, David
    Marabelle, Aurelien
    Soria, Jean-Charles
    Scoazec, Jean-Yves
    Lantuejoul, Sylvie
    ANNALES DE PATHOLOGIE, 2016, 36 (01) : 94 - 102
  • [32] PD-L1 expression is associated with advanced non-small cell lung cancer
    Chen, Zhiquan
    Mei, Jiandong
    Liu, Lunxu
    Wang, Guochen
    Li, Zuosheng
    Hou, Jingpu
    Zhang, Qiuyang
    You, Zongbing
    Zhang, Liu
    ONCOLOGY LETTERS, 2016, 12 (02) : 921 - 927
  • [33] PD-L1 expression and genotype in Non-Small Cell Lung Cancer (NSCLC)
    Ansen, S.
    Schultheis, A.
    Hellmich, M.
    Leenders, F.
    Zander, T.
    Michels, S.
    Brockmann, M.
    Stoelben, E.
    Groen, H.
    Timens, W.
    Buettner, R.
    Thomas, R. K.
    Perner, S.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2014, 37 : 5 - 6
  • [34] Clinicopathological significance of the expression of PD-L1 in non-small cell lung cancer
    Montero, M. Angeles
    Aricak, Ozan
    Kis, Lorand
    Yoshikawa, Akira
    De Petris, Luigi
    Grundberg, Oscar
    Pham, Hoa H. N.
    Roden, Anja C.
    Fukuoka, Junya
    Attanoos, Richard
    Guijarro, Ricardo
    Alarcon, Felix
    Lindstrom, Kati
    Ortiz-Villalon, Cristian
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [35] The Value of PD-L1 Expression in metastatic Lymph Nodes of Advanced Non-Small Cell Lung Cancer
    Yang, Haitang
    Hall, Sean R. R.
    Yao, Feng
    CHEST, 2020, 158 (04) : 1785 - 1787
  • [36] PD-L1 expression and genotype in non-small cell lung cancer (NSCLC).
    Ansen, Sascha
    Schultheis, Anne Maria
    Hellmich, Martin
    Zander, Thomas
    Brockmann, Michael
    Stoelben, Erich
    Groen, Harry J. M.
    Timens, Wim
    Buettner, Reinhard
    Thomas, Roman K.
    Perner, Sven
    Wolf, Juergen
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [37] MYC expression correlates with PD-L1 expression in non-small cell lung cancer
    Kim, Eun Young
    Kim, Arum
    Kim, Se Kyu
    Chang, Yoon Soo
    LUNG CANCER, 2017, 110 : 63 - 67
  • [38] ALK rearrangement is associated with high PD-L1 expression in non-small cell lung cancer
    Wang, Gang
    Ionescu, Diana
    Tucker, Tracy
    Lee, Cheng-Han
    Hiruki, Tadaaki
    Lam, Stephen
    Melosky, Barbara
    Zhou, Chen
    LABORATORY INVESTIGATION, 2019, 99
  • [39] PD-L1 Testing Patterns and Treatment in Patients With Metastatic Non-Small Cell Lung Cancer in Israel - Analysis of Real-World Data
    Apter, L.
    Moser, S. Sharman
    Arunachalam, A.
    Burke, T.
    Shalev, V.
    Chodick, G.
    Siegelmann-Danieli, N.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S307 - S308
  • [40] ALK rearrangement is associated with high PD-L1 expression in non-small cell lung cancer
    Wang, Gang
    Ionescu, Diana
    Tucker, Tracy
    Lee, Cheng-Han
    Hiruki, Tadaaki
    Lam, Stephen
    Melosky, Barbara
    Zhou, Chen
    MODERN PATHOLOGY, 2019, 32
12345